fanta.bio Sample: CNhs12234
12555 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| Asxl1 SRX3341232 | ES cells Pluripotent stem cell | 2913 / 14880 (19.6%) | 2695 / 148800 (1.8%) | −324.0 | −324.0 | 10.81 |
| Eomes SRX4904815 | Natural killer cells Blood | 3815 / 14880 (25.6%) | 3666 / 148800 (2.5%) | −324.0 | −324.0 | 10.41 |
| Epitope tags SRX13233372 | Testis Gonad | 1291 / 14880 (8.7%) | 1398 / 148800 (0.9%) | −324.0 | −324.0 | 9.23 |
| GFP SRX8244566 | Hematopoietic progenitors Blood | 1216 / 14880 (8.2%) | 1703 / 148800 (1.1%) | −324.0 | −324.0 | 7.14 |
| Med1 SRX3729400 | Hematopoietic progenitors Blood | 950 / 14880 (6.4%) | 1404 / 148800 (0.9%) | −324.0 | −324.0 | 6.77 |
| Kdm6a SRX16085105 | Hematopoietic progenitors Blood | 973 / 14880 (6.5%) | 1472 / 148800 (1.0%) | −324.0 | −324.0 | 6.61 |
| Med1 SRX3729401 | Hematopoietic progenitors Blood | 909 / 14880 (6.1%) | 1437 / 148800 (1.0%) | −324.0 | −324.0 | 6.33 |
| Kdm6a SRX16085103 | Hematopoietic progenitors Blood | 975 / 14880 (6.6%) | 1592 / 148800 (1.1%) | −324.0 | −324.0 | 6.12 |
| Brd4 SRX2522377 | Lymphoma cell lines Blood | 1002 / 14880 (6.7%) | 1671 / 148800 (1.1%) | −324.0 | −324.0 | 6.00 |
| Brd4 SRX3729384 | Hematopoietic progenitors Blood | 1366 / 14880 (9.2%) | 2323 / 148800 (1.6%) | −324.0 | −324.0 | 5.88 |
| Rag1 SRX1046534 | Thymocytes Blood | 1433 / 14880 (9.6%) | 2503 / 148800 (1.7%) | −324.0 | −324.0 | 5.73 |
| Brd4 SRX8934799 | B cells Blood | 1186 / 14880 (8.0%) | 2093 / 148800 (1.4%) | −324.0 | −324.0 | 5.67 |
| Ets1 SRX1881674 | B cells Blood | 1357 / 14880 (9.1%) | 2397 / 148800 (1.6%) | −324.0 | −324.0 | 5.66 |
| Ets1 SRX1881673 | B cells Blood | 1386 / 14880 (9.3%) | 2456 / 148800 (1.7%) | −324.0 | −324.0 | 5.64 |
| Spi1 SRX2499698 | Scid.adh.2c2 Blood | 1134 / 14880 (7.6%) | 2010 / 148800 (1.4%) | −324.0 | −324.0 | 5.64 |
| Ikzf1 SRX149204 | B3 Blood | 993 / 14880 (6.7%) | 1815 / 148800 (1.2%) | −324.0 | −324.0 | 5.47 |
| Med1 SRX206369 | Pro-B cells Blood | 1344 / 14880 (9.0%) | 2461 / 148800 (1.7%) | −324.0 | −324.0 | 5.46 |
| Brd4 SRX1465788 | B cells Blood | 1519 / 14880 (10.2%) | 2825 / 148800 (1.9%) | −324.0 | −324.0 | 5.38 |
| Bcl11b SRX12709527 | CD8+ T cells Blood | 1285 / 14880 (8.6%) | 2394 / 148800 (1.6%) | −324.0 | −324.0 | 5.37 |
| Ets1 SRX2162542 | Pre-B cells Blood | 1283 / 14880 (8.6%) | 2409 / 148800 (1.6%) | −324.0 | −324.0 | 5.33 |
| Nipbl SRX13845190 | Scid.adh.2c2 Blood | 1149 / 14880 (7.7%) | 2167 / 148800 (1.5%) | −324.0 | −324.0 | 5.30 |
| Brd4 SRX10701688 | Spleen Spleen | 1075 / 14880 (7.2%) | 2043 / 148800 (1.4%) | −324.0 | −324.0 | 5.26 |
| Ikzf1 SRX149203 | B3 Blood | 1103 / 14880 (7.4%) | 2103 / 148800 (1.4%) | −324.0 | −324.0 | 5.24 |
| Myc SRX2522382 | Lymphoma cell lines Blood | 1309 / 14880 (8.8%) | 2504 / 148800 (1.7%) | −324.0 | −324.0 | 5.23 |
| Rag2 SRX018809 | Thymocytes Blood | 1288 / 14880 (8.7%) | 2467 / 148800 (1.7%) | −324.0 | −324.0 | 5.22 |
| Runx3 SRX338019 | Natural killer cells Blood | 1088 / 14880 (7.3%) | 2087 / 148800 (1.4%) | −324.0 | −324.0 | 5.21 |
| Epitope tags SRX11667686 | Pre-B cells Blood | 1098 / 14880 (7.4%) | 2109 / 148800 (1.4%) | −324.0 | −324.0 | 5.21 |
| Spi1 SRX2499719 | Scid.adh.2c2 Blood | 1239 / 14880 (8.3%) | 2397 / 148800 (1.6%) | −324.0 | −324.0 | 5.17 |
| Runx1 SRX1939447 | Lymphoid-primed multipotent progenitors Blood | 1111 / 14880 (7.5%) | 2162 / 148800 (1.5%) | −324.0 | −324.0 | 5.14 |
| Runx1 SRX7821112 | Hematopoietic progenitors Blood | 1112 / 14880 (7.5%) | 2165 / 148800 (1.5%) | −324.0 | −324.0 | 5.14 |
| Brd4 SRX3113704 | CD4+ T cells Blood | 1377 / 14880 (9.3%) | 2691 / 148800 (1.8%) | −324.0 | −324.0 | 5.12 |
| Myc SRX5356999 | Naive B cells Blood | 1635 / 14880 (11.0%) | 3212 / 148800 (2.2%) | −324.0 | −324.0 | 5.09 |
| Nipbl SRX5730170 | B cells Blood | 1273 / 14880 (8.6%) | 2515 / 148800 (1.7%) | −324.0 | −324.0 | 5.06 |
| Nipbl SRX5730168 | B cells Blood | 1300 / 14880 (8.7%) | 2572 / 148800 (1.7%) | −324.0 | −324.0 | 5.05 |
| Myc SRX353782 | B cells Blood | 1199 / 14880 (8.1%) | 2428 / 148800 (1.6%) | −324.0 | −324.0 | 4.94 |
| Rag1 SRX1046554 | Unclassified Unclassified | 1259 / 14880 (8.5%) | 2559 / 148800 (1.7%) | −324.0 | −324.0 | 4.92 |
| Epitope tags SRX3279733 | B cells Blood | 1729 / 14880 (11.6%) | 3516 / 148800 (2.4%) | −324.0 | −324.0 | 4.92 |
| Bcl11b SRX1677236 | Thymus Blood | 1098 / 14880 (7.4%) | 2246 / 148800 (1.5%) | −324.0 | −324.0 | 4.89 |
| Stat5a SRX2975359 | Natural killer cells Blood | 1489 / 14880 (10.0%) | 3064 / 148800 (2.1%) | −324.0 | −324.0 | 4.86 |
| Med12 SRX5086066 | Th2 Cells Blood | 1603 / 14880 (10.8%) | 3306 / 148800 (2.2%) | −324.0 | −324.0 | 4.85 |
| Ets1 SRX5086093 | Th2 Cells Blood | 1409 / 14880 (9.5%) | 2907 / 148800 (2.0%) | −324.0 | −324.0 | 4.85 |
| Brd4 SRX3729385 | Hematopoietic progenitors Blood | 1387 / 14880 (9.3%) | 2882 / 148800 (1.9%) | −324.0 | −324.0 | 4.81 |
| Smarca4 SRX7807054 | Embryonic liver Embryo | 1687 / 14880 (11.3%) | 3529 / 148800 (2.4%) | −324.0 | −324.0 | 4.78 |
| Asxl1 SRX3739259 | Bone Marrow Cells Blood | 1512 / 14880 (10.2%) | 3173 / 148800 (2.1%) | −324.0 | −324.0 | 4.77 |
| Rag2 SRX1046543 | Thymocytes Blood | 2190 / 14880 (14.7%) | 4600 / 148800 (3.1%) | −324.0 | −324.0 | 4.76 |
| Myc SRX2522383 | Lymphoma cell lines Blood | 1615 / 14880 (10.9%) | 3393 / 148800 (2.3%) | −324.0 | −324.0 | 4.76 |
| Nipbl SRX320067 | CD4 CD8 double positive cells Blood | 1368 / 14880 (9.2%) | 2880 / 148800 (1.9%) | −324.0 | −324.0 | 4.75 |
| Men1 SRX415268 | Th2 Cells Blood | 1217 / 14880 (8.2%) | 2570 / 148800 (1.7%) | −324.0 | −324.0 | 4.74 |
| Erg SRX310200 | Mast Cells Blood | 1639 / 14880 (11.0%) | 3468 / 148800 (2.3%) | −324.0 | −324.0 | 4.73 |
| Hdac1 SRX1815526 | B cells Blood | 1353 / 14880 (9.1%) | 2911 / 148800 (2.0%) | −324.0 | −324.0 | 4.65 |
| Asxl1 SRX3739258 | Bone Marrow Cells Blood | 1720 / 14880 (11.6%) | 3706 / 148800 (2.5%) | −324.0 | −324.0 | 4.64 |
| Epitope tags SRX3219118 | RN2 Blood | 1512 / 14880 (10.2%) | 3263 / 148800 (2.2%) | −324.0 | −324.0 | 4.63 |
| Ets1 SRX5086097 | Th2 Cells Blood | 1671 / 14880 (11.2%) | 3626 / 148800 (2.4%) | −324.0 | −324.0 | 4.61 |
| Fli1 SRX1056338 | 416B Blood | 1378 / 14880 (9.3%) | 2994 / 148800 (2.0%) | −324.0 | −324.0 | 4.60 |
| Nipbl SRX5730166 | B cells Blood | 1719 / 14880 (11.6%) | 3757 / 148800 (2.5%) | −324.0 | −324.0 | 4.58 |
| Myc SRX5356998 | Naive B cells Blood | 2068 / 14880 (13.9%) | 4539 / 148800 (3.1%) | −324.0 | −324.0 | 4.56 |
| Erg SRX1939438 | Lymphoid-primed multipotent progenitors Blood | 1337 / 14880 (9.0%) | 2948 / 148800 (2.0%) | −324.0 | −324.0 | 4.54 |
| Erg SRX7821113 | Hematopoietic progenitors Blood | 1336 / 14880 (9.0%) | 2950 / 148800 (2.0%) | −324.0 | −324.0 | 4.53 |
| Myc SRX5357000 | Naive B cells Blood | 1958 / 14880 (13.2%) | 4324 / 148800 (2.9%) | −324.0 | −324.0 | 4.53 |
| Epitope tags SRX8244557 | Hematopoietic progenitors Blood | 3387 / 14880 (22.8%) | 7496 / 148800 (5.0%) | −324.0 | −324.0 | 4.52 |
| Bcor SRX22719795 | Leukemia Blood | 1628 / 14880 (10.9%) | 3604 / 148800 (2.4%) | −324.0 | −324.0 | 4.52 |
| Kmt2a SRX17605412 | Leukemia Blood | 1543 / 14880 (10.4%) | 3417 / 148800 (2.3%) | −324.0 | −324.0 | 4.52 |
| Nipbl SRX8694071 | B cells Blood | 1354 / 14880 (9.1%) | 3006 / 148800 (2.0%) | −324.0 | −324.0 | 4.50 |
| Bcl11b SRX1677234 | Thymus Blood | 2186 / 14880 (14.7%) | 4854 / 148800 (3.3%) | −324.0 | −324.0 | 4.50 |
| Ep300 SRX15950933 | CD4+ T cells Blood | 1463 / 14880 (9.8%) | 3252 / 148800 (2.2%) | −324.0 | −324.0 | 4.50 |
| Kmt2a SRX11002576 | Leukemia Blood | 1197 / 14880 (8.0%) | 2665 / 148800 (1.8%) | −324.0 | −324.0 | 4.49 |
| Brd4 SRX10701687 | Spleen Spleen | 1345 / 14880 (9.0%) | 2998 / 148800 (2.0%) | −324.0 | −324.0 | 4.49 |
| Brd4 SRX7799914 | CH12 Blood | 1822 / 14880 (12.2%) | 4076 / 148800 (2.7%) | −324.0 | −324.0 | 4.47 |
| Nelfb SRX11921266 | Naive T cells Blood | 1188 / 14880 (8.0%) | 2682 / 148800 (1.8%) | −324.0 | −324.0 | 4.43 |
| Epitope tags DRX165598 | Unclassified Unclassified | 1285 / 14880 (8.6%) | 2901 / 148800 (1.9%) | −324.0 | −324.0 | 4.43 |
| Kat2a SRX1815524 | B cells Blood | 1339 / 14880 (9.0%) | 3037 / 148800 (2.0%) | −324.0 | −324.0 | 4.41 |
| Kdm2b SRX22719856 | Leukemia Blood | 1868 / 14880 (12.6%) | 4255 / 148800 (2.9%) | −324.0 | −324.0 | 4.39 |
| Ets1 SRX5086095 | Th2 Cells Blood | 1738 / 14880 (11.7%) | 3961 / 148800 (2.7%) | −324.0 | −324.0 | 4.39 |
| Nipbl SRX13845191 | Scid.adh.2c2 Blood | 1715 / 14880 (11.5%) | 3930 / 148800 (2.6%) | −324.0 | −324.0 | 4.36 |
| Ets1 SRX5086094 | Th2 Cells Blood | 2253 / 14880 (15.1%) | 5164 / 148800 (3.5%) | −324.0 | −324.0 | 4.36 |
| Spi1 SRX5507842 | Spleen and lymph nodes Blood | 1441 / 14880 (9.7%) | 3305 / 148800 (2.2%) | −324.0 | −324.0 | 4.36 |
| Ep300 SRX7726474 | Natural killer cells Blood | 1242 / 14880 (8.3%) | 2861 / 148800 (1.9%) | −324.0 | −324.0 | 4.34 |
| Myc SRX353784 | B cells Blood | 1932 / 14880 (13.0%) | 4471 / 148800 (3.0%) | −324.0 | −324.0 | 4.32 |
| Nipbl SRX8694069 | B cells Blood | 1630 / 14880 (11.0%) | 3784 / 148800 (2.5%) | −324.0 | −324.0 | 4.31 |
| Cbfb SRX5780109 | CD4+ T cells Blood | 1296 / 14880 (8.7%) | 3014 / 148800 (2.0%) | −324.0 | −324.0 | 4.30 |
| Hdac1 SRX7726758 | B cells Blood | 1616 / 14880 (10.9%) | 3781 / 148800 (2.5%) | −324.0 | −324.0 | 4.27 |
| Kmt2a SRX17605406 | Granulocytic-monocytic progenitors Blood | 2028 / 14880 (13.6%) | 4748 / 148800 (3.2%) | −324.0 | −324.0 | 4.27 |
| Epitope tags SRX24288475 | Pro-B cells Blood | 1377 / 14880 (9.3%) | 3229 / 148800 (2.2%) | −324.0 | −324.0 | 4.26 |
| Runx3 SRX8718739 | T progenitor cells Blood | 1667 / 14880 (11.2%) | 3914 / 148800 (2.6%) | −324.0 | −324.0 | 4.26 |
| Runx1 SRX2499764 | Scid.adh.2c2 Blood | 2197 / 14880 (14.8%) | 5160 / 148800 (3.5%) | −324.0 | −324.0 | 4.26 |
| Bach2 SRX2200546 | Pro-B cells Blood | 1755 / 14880 (11.8%) | 4129 / 148800 (2.8%) | −324.0 | −324.0 | 4.25 |
| Spi1 SRX2499699 | Scid.adh.2c2 Blood | 1989 / 14880 (13.4%) | 4682 / 148800 (3.1%) | −324.0 | −324.0 | 4.25 |
| Runx1 SRX1438366 | EML Blood | 2469 / 14880 (16.6%) | 5813 / 148800 (3.9%) | −324.0 | −324.0 | 4.25 |
| N6amt1 SRX8338674 | Tumour organoids Others | 1255 / 14880 (8.4%) | 2959 / 148800 (2.0%) | −324.0 | −324.0 | 4.24 |
| Runx3 SRX8718716 | T progenitor cells Blood | 1707 / 14880 (11.5%) | 4032 / 148800 (2.7%) | −324.0 | −324.0 | 4.23 |
| Nipbl SRX4895107 | CH12 Blood | 1784 / 14880 (12.0%) | 4221 / 148800 (2.8%) | −324.0 | −324.0 | 4.23 |
| Runx1 DRX165596 | Unclassified Unclassified | 1410 / 14880 (9.5%) | 3337 / 148800 (2.2%) | −324.0 | −324.0 | 4.23 |
| Nipbl SRX8694068 | B cells Blood | 1471 / 14880 (9.9%) | 3491 / 148800 (2.3%) | −324.0 | −324.0 | 4.21 |
| Med12 SRX5086068 | Th2 Cells Blood | 1472 / 14880 (9.9%) | 3494 / 148800 (2.3%) | −324.0 | −324.0 | 4.21 |
| Cbfb SRX2389671 | Embryonic liver Embryo | 1987 / 14880 (13.4%) | 4719 / 148800 (3.2%) | −324.0 | −324.0 | 4.21 |
| Epitope tags SRX3279734 | B cells Blood | 2674 / 14880 (18.0%) | 6358 / 148800 (4.3%) | −324.0 | −324.0 | 4.21 |
| Ikzf1 SRX692974 | CD4 CD8 double negative cells Blood | 1482 / 14880 (10.0%) | 3526 / 148800 (2.4%) | −324.0 | −324.0 | 4.20 |
| Nipbl SRX8694070 | B cells Blood | 1484 / 14880 (10.0%) | 3542 / 148800 (2.4%) | −324.0 | −324.0 | 4.19 |
| Brd4 SRX3602867 | iPS cells Pluripotent stem cell | 1310 / 14880 (8.8%) | 3128 / 148800 (2.1%) | −324.0 | −324.0 | 4.19 |
| Runx1 SRX5358496 | Pro-B cells Blood | 2874 / 14880 (19.3%) | 6924 / 148800 (4.7%) | −324.0 | −324.0 | 4.15 |
| Ets1 SRX5086099 | Th2 Cells Blood | 2123 / 14880 (14.3%) | 5121 / 148800 (3.4%) | −324.0 | −324.0 | 4.15 |
| Bcl11b SRX1649982 | Thymus Blood | 2319 / 14880 (15.6%) | 5599 / 148800 (3.8%) | −324.0 | −324.0 | 4.14 |
| Stat4 SRX7726477 | Natural killer cells Blood | 1756 / 14880 (11.8%) | 4245 / 148800 (2.9%) | −324.0 | −324.0 | 4.14 |
| Nipbl SRX5730169 | B cells Blood | 1692 / 14880 (11.4%) | 4092 / 148800 (2.8%) | −324.0 | −324.0 | 4.13 |
| Pax5 SRX19312223 | Pro-B cells Blood | 1936 / 14880 (13.0%) | 4690 / 148800 (3.2%) | −324.0 | −324.0 | 4.13 |
| Epitope tags SRX2486172 | ES cells Pluripotent stem cell | 1407 / 14880 (9.5%) | 3413 / 148800 (2.3%) | −324.0 | −324.0 | 4.12 |
| Nipbl SRX5730164 | CH12F3 Blood | 1579 / 14880 (10.6%) | 3833 / 148800 (2.6%) | −324.0 | −324.0 | 4.12 |
| Foxp1 SRX20851843 | CD8+ T cells Blood | 1613 / 14880 (10.8%) | 3949 / 148800 (2.7%) | −324.0 | −324.0 | 4.08 |
| Bcl11b SRX1677239 | Thymus Blood | 2291 / 14880 (15.4%) | 5609 / 148800 (3.8%) | −324.0 | −324.0 | 4.08 |
| Rad21 SRX7481995 | Pro-B cells Blood | 1616 / 14880 (10.9%) | 3958 / 148800 (2.7%) | −324.0 | −324.0 | 4.08 |
| Spi1 SRX2499700 | Scid.adh.2c2 Blood | 1602 / 14880 (10.8%) | 3927 / 148800 (2.6%) | −324.0 | −324.0 | 4.08 |
| Cbfb SRX5780111 | CD8+ T cells Blood | 1777 / 14880 (11.9%) | 4363 / 148800 (2.9%) | −324.0 | −324.0 | 4.07 |
| Kmt2a SRX22719786 | Leukemia Blood | 1517 / 14880 (10.2%) | 3730 / 148800 (2.5%) | −324.0 | −324.0 | 4.07 |
| Nipbl SRX5730171 | B cells Blood | 1715 / 14880 (11.5%) | 4224 / 148800 (2.8%) | −324.0 | −324.0 | 4.06 |
| Runx1 SRX2499765 | Scid.adh.2c2 Blood | 1777 / 14880 (11.9%) | 4385 / 148800 (2.9%) | −324.0 | −324.0 | 4.05 |
| GFP SRX2486160 | C127 Breast | 1608 / 14880 (10.8%) | 3972 / 148800 (2.7%) | −324.0 | −324.0 | 4.05 |
| Rag2 SRX1046552 | B cells Blood | 2420 / 14880 (16.3%) | 5993 / 148800 (4.0%) | −324.0 | −324.0 | 4.04 |
| Foxp1 SRX20851844 | CD8+ T cells Blood | 1679 / 14880 (11.3%) | 4158 / 148800 (2.8%) | −324.0 | −324.0 | 4.04 |
| Myc SRX353783 | B cells Blood | 2450 / 14880 (16.5%) | 6070 / 148800 (4.1%) | −324.0 | −324.0 | 4.04 |
| Men1 SRX415267 | Th2 Cells Blood | 1665 / 14880 (11.2%) | 4129 / 148800 (2.8%) | −324.0 | −324.0 | 4.03 |
| Rag2 SRX1046550 | B cells Blood | 2695 / 14880 (18.1%) | 6684 / 148800 (4.5%) | −324.0 | −324.0 | 4.03 |
| Runx1 SRX2499763 | Scid.adh.2c2 Blood | 1327 / 14880 (8.9%) | 3300 / 148800 (2.2%) | −324.0 | −324.0 | 4.02 |
| Nipbl SRX8694067 | B cells Blood | 1703 / 14880 (11.4%) | 4242 / 148800 (2.9%) | −324.0 | −324.0 | 4.01 |
| Bcl11b SRX18851332 | Thymocytes Blood | 2305 / 14880 (15.5%) | 5747 / 148800 (3.9%) | −324.0 | −324.0 | 4.01 |
| Ets1 SRX5086098 | Th2 Cells Blood | 2515 / 14880 (16.9%) | 6279 / 148800 (4.2%) | −324.0 | −324.0 | 4.01 |
| Med23 SRX20509321 | CH12 Blood | 1502 / 14880 (10.1%) | 3768 / 148800 (2.5%) | −324.0 | −324.0 | 3.99 |
| Pax5 SRX19312225 | Pro-B cells Blood | 1978 / 14880 (13.3%) | 4967 / 148800 (3.3%) | −324.0 | −324.0 | 3.98 |
| Bcl11b SRX2487650 | CD4 CD8 double negative cells Blood | 2643 / 14880 (17.8%) | 6637 / 148800 (4.5%) | −324.0 | −324.0 | 3.98 |
| Tmem131 SRX3219121 | RN2 Blood | 1398 / 14880 (9.4%) | 3511 / 148800 (2.4%) | −324.0 | −324.0 | 3.98 |
| Rad21 SRX23052807 | mESC derived neural cells Pluripotent stem cell | 1372 / 14880 (9.2%) | 3449 / 148800 (2.3%) | −324.0 | −324.0 | 3.98 |
| Tet2 SRX1387481 | MEL Blood | 1418 / 14880 (9.5%) | 3570 / 148800 (2.4%) | −324.0 | −324.0 | 3.97 |
| Nipbl SRX5730167 | B cells Blood | 1622 / 14880 (10.9%) | 4092 / 148800 (2.8%) | −324.0 | −324.0 | 3.96 |
| Rag2 SRX1046542 | Thymocytes Blood | 2834 / 14880 (19.0%) | 7154 / 148800 (4.8%) | −324.0 | −324.0 | 3.96 |
| Nipbl SRX8694063 | T cells Blood | 2170 / 14880 (14.6%) | 5513 / 148800 (3.7%) | −324.0 | −324.0 | 3.94 |
| Nipbl SRX3753617 | B cells Blood | 2202 / 14880 (14.8%) | 5605 / 148800 (3.8%) | −324.0 | −324.0 | 3.93 |
| Runx1 SRX2789670 | Natural Killer T-Cells Blood | 1891 / 14880 (12.7%) | 4821 / 148800 (3.2%) | −324.0 | −324.0 | 3.92 |
| Nipbl SRX8694065 | B cells Blood | 2174 / 14880 (14.6%) | 5549 / 148800 (3.7%) | −324.0 | −324.0 | 3.92 |
| Bcor SRX22719796 | Leukemia Blood | 2190 / 14880 (14.7%) | 5599 / 148800 (3.8%) | −324.0 | −324.0 | 3.91 |
| Fli1 SRX4705104 | MLL-AF9 leukemic cell Blood | 1603 / 14880 (10.8%) | 4108 / 148800 (2.8%) | −324.0 | −324.0 | 3.90 |
| Bcl11b SRX18851333 | Thymocytes Blood | 2400 / 14880 (16.1%) | 6156 / 148800 (4.1%) | −324.0 | −324.0 | 3.90 |
| Bcl11b SRX18851331 | Thymocytes Blood | 2289 / 14880 (15.4%) | 5873 / 148800 (3.9%) | −324.0 | −324.0 | 3.90 |
| Myc SRX353785 | B cells Blood | 2467 / 14880 (16.6%) | 6330 / 148800 (4.3%) | −324.0 | −324.0 | 3.90 |
| Ep300 SRX25655383 | Leukemia Blood | 1647 / 14880 (11.1%) | 4234 / 148800 (2.8%) | −324.0 | −324.0 | 3.89 |
| Runx1 SRX1438367 | EML Blood | 2792 / 14880 (18.8%) | 7191 / 148800 (4.8%) | −324.0 | −324.0 | 3.88 |
| Epitope tags SRX3219125 | RN2 Blood | 1473 / 14880 (9.9%) | 3802 / 148800 (2.6%) | −324.0 | −324.0 | 3.87 |
| Bcl11b SRX2487652 | CD4 CD8 double negative cells Blood | 3003 / 14880 (20.2%) | 7762 / 148800 (5.2%) | −324.0 | −324.0 | 3.87 |
| Spi1 SRX091672 | CD4 CD8 double negative cells Blood | 1791 / 14880 (12.0%) | 4637 / 148800 (3.1%) | −324.0 | −324.0 | 3.86 |
| Brd4 SRX7799919 | CH12 Blood | 2316 / 14880 (15.6%) | 6021 / 148800 (4.0%) | −324.0 | −324.0 | 3.85 |
| Fli1 SRX310201 | Mast Cells Blood | 2048 / 14880 (13.8%) | 5326 / 148800 (3.6%) | −324.0 | −324.0 | 3.85 |
| Tcf3 SRX2162541 | Pre-B cells Blood | 1945 / 14880 (13.1%) | 5059 / 148800 (3.4%) | −324.0 | −324.0 | 3.84 |
| Pax5 SRX7809234 | Pro-B cells Blood | 1545 / 14880 (10.4%) | 4032 / 148800 (2.7%) | −324.0 | −324.0 | 3.83 |
| Spi1 SRX5026213 | Mast Cells Blood | 1389 / 14880 (9.3%) | 3629 / 148800 (2.4%) | −324.0 | −324.0 | 3.83 |
| Ets1 SRX2499706 | Scid.adh.2c2 Blood | 2679 / 14880 (18.0%) | 7009 / 148800 (4.7%) | −324.0 | −324.0 | 3.82 |
| Spin1 SRX2704849 | Myoblasts Muscle | 1585 / 14880 (10.7%) | 4149 / 148800 (2.8%) | −324.0 | −324.0 | 3.82 |
| Rag2 SRX1046541 | Thymocytes Blood | 2950 / 14880 (19.8%) | 7733 / 148800 (5.2%) | −324.0 | −324.0 | 3.81 |
| Kdm2b SRX22719855 | Leukemia Blood | 2386 / 14880 (16.0%) | 6256 / 148800 (4.2%) | −324.0 | −324.0 | 3.81 |
| Spi1 SRX1465791 | B cells Blood | 1458 / 14880 (9.8%) | 3824 / 148800 (2.6%) | −324.0 | −324.0 | 3.81 |
| Nipbl SRX8694066 | B cells Blood | 1686 / 14880 (11.3%) | 4425 / 148800 (3.0%) | −324.0 | −324.0 | 3.81 |
| Nelfe SRX140395 | MEL Blood | 1613 / 14880 (10.8%) | 4238 / 148800 (2.8%) | −324.0 | −324.0 | 3.81 |
| Pax5 SRX11976741 | Pro-B cells Blood | 2413 / 14880 (16.2%) | 6346 / 148800 (4.3%) | −324.0 | −324.0 | 3.80 |
| Pax5 SRX7809233 | Pro-B cells Blood | 1410 / 14880 (9.5%) | 3709 / 148800 (2.5%) | −324.0 | −324.0 | 3.80 |
| Fli1 SRX1939439 | Lymphoid-primed multipotent progenitors Blood | 1824 / 14880 (12.3%) | 4808 / 148800 (3.2%) | −324.0 | −324.0 | 3.79 |
| Egr2 SRX270570 | CD4+ T cells Blood | 1565 / 14880 (10.5%) | 4126 / 148800 (2.8%) | −324.0 | −324.0 | 3.79 |
| Bach2 SRX2200545 | Pro-B cells Blood | 1941 / 14880 (13.0%) | 5123 / 148800 (3.4%) | −324.0 | −324.0 | 3.79 |
| Fli1 SRX7821115 | Hematopoietic progenitors Blood | 1822 / 14880 (12.2%) | 4809 / 148800 (3.2%) | −324.0 | −324.0 | 3.79 |
| Nipbl SRX4895127 | CH12 Blood | 2575 / 14880 (17.3%) | 6804 / 148800 (4.6%) | −324.0 | −324.0 | 3.78 |
| Pax5 SRX7809235 | Pro-B cells Blood | 1541 / 14880 (10.4%) | 4076 / 148800 (2.7%) | −324.0 | −324.0 | 3.78 |
| Ets1 SRX2499705 | Scid.adh.2c2 Blood | 2718 / 14880 (18.3%) | 7192 / 148800 (4.8%) | −324.0 | −324.0 | 3.78 |
| Nipbl SRX2755276 | B cells Blood | 2458 / 14880 (16.5%) | 6514 / 148800 (4.4%) | −324.0 | −324.0 | 3.77 |
| Brd4 SRX376583 | MLL-AF9 leukemic cell Blood | 2104 / 14880 (14.1%) | 5576 / 148800 (3.7%) | −324.0 | −324.0 | 3.77 |
| Rbfox2 SRX551545 | MEF Embryonic fibroblast | 1710 / 14880 (11.5%) | 4533 / 148800 (3.0%) | −324.0 | −324.0 | 3.77 |
| Spi1 SRX5026212 | Mast Cells Blood | 1452 / 14880 (9.8%) | 3850 / 148800 (2.6%) | −324.0 | −324.0 | 3.77 |
| Kmt2a SRX25655413 | Leukemia Blood | 1436 / 14880 (9.7%) | 3821 / 148800 (2.6%) | −324.0 | −324.0 | 3.76 |
| Ets1 SRX2499704 | Scid.adh.2c2 Blood | 2685 / 14880 (18.0%) | 7153 / 148800 (4.8%) | −324.0 | −324.0 | 3.75 |
| Runx3 SRX8718717 | T progenitor cells Blood | 2119 / 14880 (14.2%) | 5650 / 148800 (3.8%) | −324.0 | −324.0 | 3.75 |
| Wdr5 SRX1815529 | B cells Blood | 1881 / 14880 (12.6%) | 5028 / 148800 (3.4%) | −324.0 | −324.0 | 3.74 |
| Tcf7 SRX24130478 | Thymocytes Blood | 1410 / 14880 (9.5%) | 3769 / 148800 (2.5%) | −324.0 | −324.0 | 3.74 |
| Kmt2a SRX17605411 | Leukemia Blood | 2286 / 14880 (15.4%) | 6127 / 148800 (4.1%) | −324.0 | −324.0 | 3.73 |
| Hdac1 SRX7726755 | B cells Blood | 1870 / 14880 (12.6%) | 5013 / 148800 (3.4%) | −324.0 | −324.0 | 3.73 |
| Biotin SRX10950530 | Pro-B cells Blood | 1571 / 14880 (10.6%) | 4219 / 148800 (2.8%) | −324.0 | −324.0 | 3.72 |
| Spi1 SRX5026214 | Mast Cells Blood | 1624 / 14880 (10.9%) | 4365 / 148800 (2.9%) | −324.0 | −324.0 | 3.72 |
| Fli1 SRX4705106 | MLL-AF9 leukemic cell Blood | 1508 / 14880 (10.1%) | 4056 / 148800 (2.7%) | −324.0 | −324.0 | 3.72 |
| Cbfb SRX2389673 | Thymocytes Blood | 2176 / 14880 (14.6%) | 5855 / 148800 (3.9%) | −324.0 | −324.0 | 3.72 |
| Rag2 SRX1046545 | Thymocytes Blood | 3044 / 14880 (20.5%) | 8199 / 148800 (5.5%) | −324.0 | −324.0 | 3.71 |
| GFP SRX2486159 | C127 Breast | 1935 / 14880 (13.0%) | 5225 / 148800 (3.5%) | −324.0 | −324.0 | 3.70 |
| Ikzf3 SRX10166890 | Thymocytes Blood | 2098 / 14880 (14.1%) | 5668 / 148800 (3.8%) | −324.0 | −324.0 | 3.70 |
| Bcl11b SRX18851328 | Thymocytes Blood | 2189 / 14880 (14.7%) | 5921 / 148800 (4.0%) | −324.0 | −324.0 | 3.70 |
| Pax5 SRX7809236 | Pro-B cells Blood | 1820 / 14880 (12.2%) | 4941 / 148800 (3.3%) | −324.0 | −324.0 | 3.68 |
| Med26 SRX20509320 | CH12 Blood | 2032 / 14880 (13.7%) | 5518 / 148800 (3.7%) | −324.0 | −324.0 | 3.68 |
| Spi1 SRX5026211 | Mast Cells Blood | 1602 / 14880 (10.8%) | 4355 / 148800 (2.9%) | −324.0 | −324.0 | 3.68 |
| Crebbp SRX25655381 | Leukemia Blood | 1992 / 14880 (13.4%) | 5422 / 148800 (3.6%) | −324.0 | −324.0 | 3.67 |
| Nipbl SRX3753614 | B cells Blood | 1654 / 14880 (11.1%) | 4502 / 148800 (3.0%) | −324.0 | −324.0 | 3.67 |
| Ikzf1 SRX20340935 | Pre-B cells Blood | 1454 / 14880 (9.8%) | 3963 / 148800 (2.7%) | −324.0 | −324.0 | 3.67 |
| Yy1 SRX14617702 | CH12 Blood | 1840 / 14880 (12.4%) | 5023 / 148800 (3.4%) | −324.0 | −324.0 | 3.66 |
| Nipbl SRX2755277 | B cells Blood | 2769 / 14880 (18.6%) | 7579 / 148800 (5.1%) | −324.0 | −324.0 | 3.65 |
| Runx1 SRX5358488 | Pro-B cells Blood | 1963 / 14880 (13.2%) | 5373 / 148800 (3.6%) | −324.0 | −324.0 | 3.65 |
| Runx1 SRX5358492 | Pro-B cells Blood | 3237 / 14880 (21.8%) | 8869 / 148800 (6.0%) | −324.0 | −324.0 | 3.65 |
| Ikzf1 SRX2162555 | Pre-B cells Blood | 1456 / 14880 (9.8%) | 3999 / 148800 (2.7%) | −324.0 | −324.0 | 3.64 |
| Pax5 SRX19312224 | Pro-B cells Blood | 2513 / 14880 (16.9%) | 6903 / 148800 (4.6%) | −324.0 | −324.0 | 3.64 |
| Kdm1a SRX181863 | Granulocytes Blood | 1593 / 14880 (10.7%) | 4387 / 148800 (2.9%) | −324.0 | −324.0 | 3.63 |
| Nipbl SRX3753616 | B cells Blood | 2628 / 14880 (17.7%) | 7268 / 148800 (4.9%) | −324.0 | −324.0 | 3.62 |
| Runx1 SRX2499762 | Scid.adh.2c2 Blood | 2240 / 14880 (15.1%) | 6195 / 148800 (4.2%) | −324.0 | −324.0 | 3.62 |
| Bcor SRX22719813 | Leukemia Blood | 1758 / 14880 (11.8%) | 4862 / 148800 (3.3%) | −324.0 | −324.0 | 3.62 |
| Sin3a SRX22262965 | Beta-TC-6 Pancreas | 1568 / 14880 (10.5%) | 4337 / 148800 (2.9%) | −324.0 | −324.0 | 3.62 |
| Spi1 SRX5026215 | Mast Cells Blood | 1683 / 14880 (11.3%) | 4662 / 148800 (3.1%) | −324.0 | −324.0 | 3.61 |
| Hdac1 SRX9519542 | G1E Blood | 2075 / 14880 (13.9%) | 5756 / 148800 (3.9%) | −324.0 | −324.0 | 3.60 |
| Wdr5 SRX1815515 | B cells Blood | 1774 / 14880 (11.9%) | 4927 / 148800 (3.3%) | −324.0 | −324.0 | 3.60 |
| Rag2 SRX1046553 | B cells Blood | 3019 / 14880 (20.3%) | 8389 / 148800 (5.6%) | −324.0 | −324.0 | 3.60 |
| Spi1 SRX2499724 | Scid.adh.2c2 Blood | 1740 / 14880 (11.7%) | 4837 / 148800 (3.3%) | −324.0 | −324.0 | 3.60 |
| Spi1 SRX091673 | CD4 CD8 double negative cells Blood | 1774 / 14880 (11.9%) | 4951 / 148800 (3.3%) | −324.0 | −324.0 | 3.58 |
| Stat5a SRX15950931 | CD4+ T cells Blood | 2007 / 14880 (13.5%) | 5602 / 148800 (3.8%) | −324.0 | −324.0 | 3.58 |
| Kdm6b SRX621433 | CD4+ T cells Blood | 1731 / 14880 (11.6%) | 4836 / 148800 (3.3%) | −324.0 | −324.0 | 3.58 |
| Rnf2 SRX9633976 | B cells Blood | 2075 / 14880 (13.9%) | 5811 / 148800 (3.9%) | −324.0 | −324.0 | 3.57 |
| Runx1 SRX1892671 | 416B Blood | 1501 / 14880 (10.1%) | 4205 / 148800 (2.8%) | −324.0 | −324.0 | 3.57 |
| Spi1 SRX2499701 | Scid.adh.2c2 Blood | 1892 / 14880 (12.7%) | 5311 / 148800 (3.6%) | −324.0 | −324.0 | 3.56 |
| Mllt3 SRX1902738 | Acute myeloid leukemia Blood | 2170 / 14880 (14.6%) | 6112 / 148800 (4.1%) | −324.0 | −324.0 | 3.55 |
| Bcl11b SRX18851329 | Thymocytes Blood | 2712 / 14880 (18.2%) | 7678 / 148800 (5.2%) | −324.0 | −324.0 | 3.53 |
| Hdac1 SRX1815525 | B cells Blood | 3026 / 14880 (20.3%) | 8567 / 148800 (5.8%) | −324.0 | −324.0 | 3.53 |
| Nipbl SRX4895128 | CH12 Blood | 2881 / 14880 (19.4%) | 8164 / 148800 (5.5%) | −324.0 | −324.0 | 3.53 |
| Bcl11b SRX18851330 | Thymocytes Blood | 2658 / 14880 (17.9%) | 7537 / 148800 (5.1%) | −324.0 | −324.0 | 3.53 |
| Smarca4 SRX7807050 | Embryonic liver Embryo | 2632 / 14880 (17.7%) | 7475 / 148800 (5.0%) | −324.0 | −324.0 | 3.52 |
| Smarca4 SRX7807053 | Embryonic liver Embryo | 2489 / 14880 (16.7%) | 7076 / 148800 (4.8%) | −324.0 | −324.0 | 3.52 |
| Nipbl SRX8694064 | T cells Blood | 2263 / 14880 (15.2%) | 6452 / 148800 (4.3%) | −324.0 | −324.0 | 3.51 |
| Hdac1 SRX7726756 | B cells Blood | 2001 / 14880 (13.4%) | 5718 / 148800 (3.8%) | −324.0 | −324.0 | 3.50 |
| Sin3a SRX22262966 | Beta-TC-6 Pancreas | 1610 / 14880 (10.8%) | 4605 / 148800 (3.1%) | −324.0 | −324.0 | 3.50 |
| Batf SRX10150718 | CD8+ T cells Blood | 1672 / 14880 (11.2%) | 4797 / 148800 (3.2%) | −324.0 | −324.0 | 3.49 |
| Bcl11b SRX3660780 | CD4 CD8 double negative cells Blood | 3320 / 14880 (22.3%) | 9526 / 148800 (6.4%) | −324.0 | −324.0 | 3.49 |
| Brd4 SRX8379040 | Macrophages Blood | 1875 / 14880 (12.6%) | 5393 / 148800 (3.6%) | −324.0 | −324.0 | 3.48 |
| Kmt2a SRX1815528 | B cells Blood | 2814 / 14880 (18.9%) | 8094 / 148800 (5.4%) | −324.0 | −324.0 | 3.48 |
| Gata3 SRX2499768 | Scid.adh.2c2 Blood | 1807 / 14880 (12.1%) | 5198 / 148800 (3.5%) | −324.0 | −324.0 | 3.48 |
| Tbp SRX22599847 | NIH/3T3 Embryonic fibroblast | 2042 / 14880 (13.7%) | 5875 / 148800 (3.9%) | −324.0 | −324.0 | 3.48 |
| Runx1 SRX3195533 | CD4 CD8 double negative cells Blood | 2429 / 14880 (16.3%) | 6991 / 148800 (4.7%) | −324.0 | −324.0 | 3.47 |
| Mta2 SRX3660756 | CD4 CD8 double negative cells Blood | 1845 / 14880 (12.4%) | 5315 / 148800 (3.6%) | −324.0 | −324.0 | 3.47 |
| Rnf2 SRX9633974 | B cells Blood | 2294 / 14880 (15.4%) | 6618 / 148800 (4.4%) | −324.0 | −324.0 | 3.47 |
| Brd4 SRX8379041 | Macrophages Blood | 1888 / 14880 (12.7%) | 5449 / 148800 (3.7%) | −324.0 | −324.0 | 3.46 |
| Hdac1 SRX9519543 | G1E Blood | 2269 / 14880 (15.2%) | 6550 / 148800 (4.4%) | −324.0 | −324.0 | 3.46 |
| Kmt2a SRX1815514 | B cells Blood | 2996 / 14880 (20.1%) | 8654 / 148800 (5.8%) | −324.0 | −324.0 | 3.46 |
| Nfya SRX12799801 | Acute myeloid leukemia Blood | 1540 / 14880 (10.3%) | 4450 / 148800 (3.0%) | −324.0 | −324.0 | 3.46 |
| Pax5 SRX19312226 | Pro-B cells Blood | 2460 / 14880 (16.5%) | 7109 / 148800 (4.8%) | −324.0 | −324.0 | 3.46 |
| Mta2 SRX1205896 | CD4 CD8 double negative cells Blood | 2626 / 14880 (17.6%) | 7596 / 148800 (5.1%) | −324.0 | −324.0 | 3.46 |
| Kmt2a SRX17605409 | Monocytes Blood | 1551 / 14880 (10.4%) | 4491 / 148800 (3.0%) | −324.0 | −324.0 | 3.45 |
| Kdm2b SRX22719874 | Leukemia Blood | 1568 / 14880 (10.5%) | 4551 / 148800 (3.1%) | −324.0 | −324.0 | 3.45 |
| Tfap4 SRX554972 | CD8+ T cells Blood | 1871 / 14880 (12.6%) | 5440 / 148800 (3.7%) | −324.0 | −324.0 | 3.44 |
| Tcf3 SRX1568859 | B cells Blood | 1652 / 14880 (11.1%) | 4810 / 148800 (3.2%) | −324.0 | −324.0 | 3.43 |
| Spi1 SRX5026216 | Mast Cells Blood | 1931 / 14880 (13.0%) | 5627 / 148800 (3.8%) | −324.0 | −324.0 | 3.43 |
| Egr2 SRX270569 | CD4+ T cells Blood | 1713 / 14880 (11.5%) | 5014 / 148800 (3.4%) | −324.0 | −324.0 | 3.42 |
| Pax5 SRX5358483 | Pro-B cells Blood | 1642 / 14880 (11.0%) | 4810 / 148800 (3.2%) | −324.0 | −324.0 | 3.41 |
| Kdm2b SRX22719876 | Leukemia Blood | 2215 / 14880 (14.9%) | 6495 / 148800 (4.4%) | −324.0 | −324.0 | 3.41 |
| Runx2 SRX4705109 | MLL-AF9 leukemic cell Blood | 2311 / 14880 (15.5%) | 6780 / 148800 (4.6%) | −324.0 | −324.0 | 3.41 |
| Bcl11b SRX12709528 | CD8+ T cells Blood | 2089 / 14880 (14.0%) | 6138 / 148800 (4.1%) | −324.0 | −324.0 | 3.40 |
| Hdac2 SRX3660790 | Scid.adh.2c2 Blood | 2419 / 14880 (16.3%) | 7111 / 148800 (4.8%) | −324.0 | −324.0 | 3.40 |
| Chd4 SRX1815523 | B cells Blood | 3042 / 14880 (20.4%) | 8964 / 148800 (6.0%) | −324.0 | −324.0 | 3.39 |
| Batf SRX10150717 | CD8+ T cells Blood | 1680 / 14880 (11.3%) | 4954 / 148800 (3.3%) | −324.0 | −324.0 | 3.39 |
| Nipbl SRX3753615 | B cells Blood | 2612 / 14880 (17.6%) | 7716 / 148800 (5.2%) | −324.0 | −324.0 | 3.39 |
| Runx1 SRX5358482 | Pro-B cells Blood | 3328 / 14880 (22.4%) | 9848 / 148800 (6.6%) | −324.0 | −324.0 | 3.38 |
| Nipbl SRX4895106 | CH12 Blood | 2802 / 14880 (18.8%) | 8293 / 148800 (5.6%) | −324.0 | −324.0 | 3.38 |
| Bcl11b SRX3660779 | CD4 CD8 double negative cells Blood | 3615 / 14880 (24.3%) | 10712 / 148800 (7.2%) | −324.0 | −324.0 | 3.37 |
| Pax5 SRX11976740 | Pro-B cells Blood | 2295 / 14880 (15.4%) | 6803 / 148800 (4.6%) | −324.0 | −324.0 | 3.37 |
| Brd4 SRX884070 | MLL-AF9 leukemic cell Blood | 1603 / 14880 (10.8%) | 4753 / 148800 (3.2%) | −324.0 | −324.0 | 3.37 |
| Stat4 SRX7726479 | Natural killer cells Blood | 2296 / 14880 (15.4%) | 6809 / 148800 (4.6%) | −324.0 | −324.0 | 3.37 |
| Runx3 SRX8718740 | T progenitor cells Blood | 2785 / 14880 (18.7%) | 8262 / 148800 (5.6%) | −324.0 | −324.0 | 3.37 |
| Ikzf3 SRX10166891 | Thymocytes Blood | 2151 / 14880 (14.5%) | 6402 / 148800 (4.3%) | −324.0 | −324.0 | 3.36 |
| Rnf2 SRX3660767 | CD4 CD8 double negative cells Blood | 2205 / 14880 (14.8%) | 6565 / 148800 (4.4%) | −324.0 | −324.0 | 3.36 |
| Zfp281 SRX16019903 | Th2 Cells Blood | 1852 / 14880 (12.4%) | 5515 / 148800 (3.7%) | −324.0 | −324.0 | 3.36 |
| Mta2 SRX3660755 | CD4 CD8 double negative cells Blood | 2012 / 14880 (13.5%) | 5994 / 148800 (4.0%) | −324.0 | −324.0 | 3.36 |
| Hdac2 SRX3660789 | Scid.adh.2c2 Blood | 2704 / 14880 (18.2%) | 8063 / 148800 (5.4%) | −324.0 | −324.0 | 3.35 |
| Rnf2 SRX9633975 | B cells Blood | 2451 / 14880 (16.5%) | 7322 / 148800 (4.9%) | −324.0 | −324.0 | 3.35 |
| Epitope tags SRX3219123 | RN2 Blood | 2867 / 14880 (19.3%) | 8572 / 148800 (5.8%) | −324.0 | −324.0 | 3.34 |
| Rbfox2 SRX551553 | MEF Embryonic fibroblast | 1637 / 14880 (11.0%) | 4907 / 148800 (3.3%) | −324.0 | −324.0 | 3.34 |
| Runx2 SRX4705110 | MLL-AF9 leukemic cell Blood | 2360 / 14880 (15.9%) | 7100 / 148800 (4.8%) | −324.0 | −324.0 | 3.32 |
| Yy1 SRX14617670 | CH12 Blood | 2393 / 14880 (16.1%) | 7201 / 148800 (4.8%) | −324.0 | −324.0 | 3.32 |
| GFP SRX8244559 | Hematopoietic progenitors Blood | 3639 / 14880 (24.5%) | 10991 / 148800 (7.4%) | −324.0 | −324.0 | 3.31 |
| Stat4 SRX7726478 | Natural killer cells Blood | 2441 / 14880 (16.4%) | 7401 / 148800 (5.0%) | −324.0 | −324.0 | 3.30 |
| Spi1 SRX2499686 | CD25+ cells Blood | 2566 / 14880 (17.2%) | 7786 / 148800 (5.2%) | −324.0 | −324.0 | 3.30 |
| Cbfb SRX2389674 | Thymocytes Blood | 3413 / 14880 (22.9%) | 10376 / 148800 (7.0%) | −324.0 | −324.0 | 3.29 |
| Cbfb SRX2389672 | Thymocytes Blood | 3518 / 14880 (23.6%) | 10710 / 148800 (7.2%) | −324.0 | −324.0 | 3.28 |
| Spi1 SRX7692793 | Eosinophils Blood | 1791 / 14880 (12.0%) | 5460 / 148800 (3.7%) | −324.0 | −324.0 | 3.28 |
| Smarca4 SRX7807052 | Embryonic liver Embryo | 2991 / 14880 (20.1%) | 9128 / 148800 (6.1%) | −324.0 | −324.0 | 3.28 |
| Ep300 SRX7726459 | Natural killer cells Blood | 1932 / 14880 (13.0%) | 5906 / 148800 (4.0%) | −324.0 | −324.0 | 3.27 |
| Pax5 SRX10950551 | Pro-B cells Blood | 2094 / 14880 (14.1%) | 6404 / 148800 (4.3%) | −324.0 | −324.0 | 3.27 |
| Kdm2b SRX22719878 | Leukemia Blood | 1884 / 14880 (12.7%) | 5775 / 148800 (3.9%) | −324.0 | −324.0 | 3.26 |
| Spi1 SRX5026210 | Mast Cells Blood | 2307 / 14880 (15.5%) | 7082 / 148800 (4.8%) | −324.0 | −324.0 | 3.26 |
| Yy1 SRX14617672 | CH12 Blood | 2430 / 14880 (16.3%) | 7465 / 148800 (5.0%) | −324.0 | −324.0 | 3.26 |
| Foxp3 SRX2341417 | Treg Blood | 1871 / 14880 (12.6%) | 5752 / 148800 (3.9%) | −324.0 | −324.0 | 3.25 |
| Med1 SRX1403503 | MLL-AF9 leukemic cell Blood | 1874 / 14880 (12.6%) | 5762 / 148800 (3.9%) | −324.0 | −324.0 | 3.25 |
| Spi1 SRX2499721 | Scid.adh.2c2 Blood | 2167 / 14880 (14.6%) | 6673 / 148800 (4.5%) | −324.0 | −324.0 | 3.25 |
| Spi1 SRX2499722 | Scid.adh.2c2 Blood | 1916 / 14880 (12.9%) | 5912 / 148800 (4.0%) | −324.0 | −324.0 | 3.24 |
| Smarca4 SRX7807051 | Embryonic liver Embryo | 3173 / 14880 (21.3%) | 9816 / 148800 (6.6%) | −324.0 | −324.0 | 3.23 |
| Satb1 SRX13440924 | Thymus Blood | 2208 / 14880 (14.8%) | 6852 / 148800 (4.6%) | −324.0 | −324.0 | 3.22 |
| Pax5 SRX5358487 | Pro-B cells Blood | 1890 / 14880 (12.7%) | 5880 / 148800 (4.0%) | −324.0 | −324.0 | 3.21 |
| Taf1 SRX19028407 | ES cells Pluripotent stem cell | 1711 / 14880 (11.5%) | 5330 / 148800 (3.6%) | −324.0 | −324.0 | 3.21 |
| Hdac2 SRX1815527 | B cells Blood | 3060 / 14880 (20.6%) | 9537 / 148800 (6.4%) | −324.0 | −324.0 | 3.21 |
| Kdm2b SRX22719877 | Leukemia Blood | 3005 / 14880 (20.2%) | 9386 / 148800 (6.3%) | −324.0 | −324.0 | 3.20 |
| Yy1 SRX14617701 | CH12 Blood | 2495 / 14880 (16.8%) | 7818 / 148800 (5.3%) | −324.0 | −324.0 | 3.19 |
| Gata3 SRX2499769 | Scid.adh.2c2 Blood | 2545 / 14880 (17.1%) | 7980 / 148800 (5.4%) | −324.0 | −324.0 | 3.19 |
| Lmo2 SRX7821114 | Hematopoietic progenitors Blood | 2278 / 14880 (15.3%) | 7154 / 148800 (4.8%) | −324.0 | −324.0 | 3.18 |
| Stat5a SRX17605414 | Leukemia Blood | 1773 / 14880 (11.9%) | 5573 / 148800 (3.7%) | −324.0 | −324.0 | 3.18 |
| Lmo2 SRX1939444 | Lymphoid-primed multipotent progenitors Blood | 2275 / 14880 (15.3%) | 7159 / 148800 (4.8%) | −324.0 | −324.0 | 3.18 |
| Yy1 SRX14617700 | CH12 Blood | 2494 / 14880 (16.8%) | 7865 / 148800 (5.3%) | −324.0 | −324.0 | 3.17 |
| Runx1 SRX3195535 | CD4 CD8 double negative cells Blood | 2852 / 14880 (19.2%) | 9026 / 148800 (6.1%) | −324.0 | −324.0 | 3.16 |
| Mxi1 SRX140388 | CH12 Blood | 2327 / 14880 (15.6%) | 7372 / 148800 (5.0%) | −324.0 | −324.0 | 3.16 |
| Kdm6b SRX621429 | CD4+ T cells Blood | 3131 / 14880 (21.0%) | 9937 / 148800 (6.7%) | −324.0 | −324.0 | 3.15 |
| Max SRX9432515 | RAW 264.7 Blood | 2182 / 14880 (14.7%) | 6927 / 148800 (4.7%) | −324.0 | −324.0 | 3.15 |
| Yy1 SRX14617671 | CH12 Blood | 2534 / 14880 (17.0%) | 8061 / 148800 (5.4%) | −324.0 | −324.0 | 3.14 |
| Brd4 SRX1114541 | MLL-AF9 leukemic cell Blood | 3592 / 14880 (24.1%) | 11427 / 148800 (7.7%) | −324.0 | −324.0 | 3.14 |
| Spi1 SRX2499725 | Scid.adh.2c2 Blood | 2103 / 14880 (14.1%) | 6695 / 148800 (4.5%) | −324.0 | −324.0 | 3.14 |
| Nfib SRX19694889 | C3H/10T1/2 Embryonic fibroblast | 1792 / 14880 (12.0%) | 5708 / 148800 (3.8%) | −324.0 | −324.0 | 3.14 |
| Irf4 SRX2162565 | Pre-B cells Blood | 2471 / 14880 (16.6%) | 7879 / 148800 (5.3%) | −324.0 | −324.0 | 3.14 |
| Gfi1 SRX093162 | Bone Marrow Cells Blood | 1978 / 14880 (13.3%) | 6313 / 148800 (4.2%) | −324.0 | −324.0 | 3.13 |
| Spi1 SRX2499687 | CD25+ cells Blood | 2592 / 14880 (17.4%) | 8275 / 148800 (5.6%) | −324.0 | −324.0 | 3.13 |
| Spi1 SRX1131940 | Plasmablasts Blood | 1933 / 14880 (13.0%) | 6176 / 148800 (4.2%) | −324.0 | −324.0 | 3.13 |
| Nfib SRX19694891 | C3H/10T1/2 Embryonic fibroblast | 1925 / 14880 (12.9%) | 6152 / 148800 (4.1%) | −324.0 | −324.0 | 3.13 |
| Nfib SRX19694893 | C3H/10T1/2 Embryonic fibroblast | 1842 / 14880 (12.4%) | 5898 / 148800 (4.0%) | −324.0 | −324.0 | 3.12 |
| Hcfc1 SRX188798 | MEL Blood | 1790 / 14880 (12.0%) | 5736 / 148800 (3.9%) | −324.0 | −324.0 | 3.12 |
| Foxp3 SRX2341414 | Treg Blood | 1883 / 14880 (12.7%) | 6045 / 148800 (4.1%) | −324.0 | −324.0 | 3.11 |
| Spi1 SRX2499723 | Scid.adh.2c2 Blood | 2248 / 14880 (15.1%) | 7221 / 148800 (4.9%) | −324.0 | −324.0 | 3.11 |
| Brd4 SRX1403500 | MLL-AF9 leukemic cell Blood | 2646 / 14880 (17.8%) | 8502 / 148800 (5.7%) | −324.0 | −324.0 | 3.11 |
| Nr3c1 SRX4615042 | Lung endothelial cells Cardiovascular | 1962 / 14880 (13.2%) | 6305 / 148800 (4.2%) | −324.0 | −324.0 | 3.11 |
| Spi1 SRX2341952 | LSK cells Blood | 1768 / 14880 (11.9%) | 5682 / 148800 (3.8%) | −324.0 | −324.0 | 3.11 |
| Smarca4 SRX1815522 | B cells Blood | 3539 / 14880 (23.8%) | 11381 / 148800 (7.6%) | −324.0 | −324.0 | 3.11 |
| Kmt2a SRX17605403 | Granulocytic-monocytic progenitors Blood | 3099 / 14880 (20.8%) | 9977 / 148800 (6.7%) | −324.0 | −324.0 | 3.11 |
| Nfib SRX19694894 | C3H/10T1/2 Embryonic fibroblast | 1998 / 14880 (13.4%) | 6444 / 148800 (4.3%) | −324.0 | −324.0 | 3.10 |
| Bcl11b SRX2399085 | Thymocytes Blood | 3670 / 14880 (24.7%) | 11858 / 148800 (8.0%) | −324.0 | −324.0 | 3.09 |
| Runx1 SRX825830 | mESC derived haematopoietic progenitor Pluripotent stem cell | 2006 / 14880 (13.5%) | 6482 / 148800 (4.4%) | −324.0 | −324.0 | 3.09 |
| Kdm4c SRX1755829 | Granulocytic-monocytic progenitors Blood | 2013 / 14880 (13.5%) | 6515 / 148800 (4.4%) | −324.0 | −324.0 | 3.09 |
| Sap130 SRX1568882 | Embryonic heart Embryo | 2072 / 14880 (13.9%) | 6717 / 148800 (4.5%) | −324.0 | −324.0 | 3.08 |
| Rnf2 SRX3660769 | Bone Marrow Cells Blood | 2034 / 14880 (13.7%) | 6618 / 148800 (4.4%) | −324.0 | −324.0 | 3.07 |
| Pax5 SRX10950550 | Pro-B cells Blood | 2740 / 14880 (18.4%) | 8923 / 148800 (6.0%) | −324.0 | −324.0 | 3.07 |
| Phf8 SRX2396659 | Prostate Prostate | 2033 / 14880 (13.7%) | 6623 / 148800 (4.5%) | −324.0 | −324.0 | 3.07 |
| Ikzf1 SRX205987 | B cells Blood | 2751 / 14880 (18.5%) | 8983 / 148800 (6.0%) | −324.0 | −324.0 | 3.06 |
| Nr3c1 SRX4615041 | Lung endothelial cells Cardiovascular | 1909 / 14880 (12.8%) | 6261 / 148800 (4.2%) | −324.0 | −324.0 | 3.05 |
| Chd4 SRX1815509 | B cells Blood | 1972 / 14880 (13.3%) | 6472 / 148800 (4.3%) | −324.0 | −324.0 | 3.05 |
| Spi1 SRX2341957 | Hematopoietic Stem Cells Blood | 1878 / 14880 (12.6%) | 6165 / 148800 (4.1%) | −324.0 | −324.0 | 3.05 |
| Ep300 SRX1565831 | Natural killer cells Blood | 2088 / 14880 (14.0%) | 6863 / 148800 (4.6%) | −324.0 | −324.0 | 3.04 |
| Ep300 SRX1565832 | Natural killer cells Blood | 1955 / 14880 (13.1%) | 6449 / 148800 (4.3%) | −324.0 | −324.0 | 3.03 |
| Ikzf3 SRX10166889 | Thymocytes Blood | 3336 / 14880 (22.4%) | 11017 / 148800 (7.4%) | −324.0 | −324.0 | 3.03 |
| Spi1 SRX2499696 | Scid.adh.2c2 Blood | 2344 / 14880 (15.8%) | 7741 / 148800 (5.2%) | −324.0 | −324.0 | 3.03 |
| Ikzf3 SRX10166886 | Thymocytes Blood | 2253 / 14880 (15.1%) | 7466 / 148800 (5.0%) | −324.0 | −324.0 | 3.02 |
| Smarca4 SRX1815508 | B cells Blood | 3589 / 14880 (24.1%) | 11932 / 148800 (8.0%) | −324.0 | −324.0 | 3.01 |
| Med1 SRX1403502 | MLL-AF9 leukemic cell Blood | 2392 / 14880 (16.1%) | 7953 / 148800 (5.3%) | −324.0 | −324.0 | 3.01 |
| Rnf2 SRX3660768 | CD4 CD8 double negative cells Blood | 2494 / 14880 (16.8%) | 8293 / 148800 (5.6%) | −324.0 | −324.0 | 3.01 |
| Biotin SRX13366572 | Plasmablasts Blood | 1895 / 14880 (12.7%) | 6304 / 148800 (4.2%) | −324.0 | −324.0 | 3.01 |
| Phf8 SRX2396657 | Prostate Prostate | 2164 / 14880 (14.5%) | 7205 / 148800 (4.8%) | −324.0 | −324.0 | 3.00 |
| Rad21 SRX7481994 | Pro-B cells Blood | 1999 / 14880 (13.4%) | 6667 / 148800 (4.5%) | −324.0 | −324.0 | 3.00 |
| Smc1a SRX7348142 | Thymocytes Blood | 2075 / 14880 (13.9%) | 6940 / 148800 (4.7%) | −324.0 | −324.0 | 2.99 |
| Chd4 SRX3660751 | CD4 CD8 double negative cells Blood | 1979 / 14880 (13.3%) | 6632 / 148800 (4.5%) | −324.0 | −324.0 | 2.98 |
| Spi1 SRX2499682 | CD25+ cells Blood | 2132 / 14880 (14.3%) | 7150 / 148800 (4.8%) | −324.0 | −324.0 | 2.98 |
| Smc1a SRX7348145 | CD4 CD8 double positive cells Blood | 2481 / 14880 (16.7%) | 8321 / 148800 (5.6%) | −324.0 | −324.0 | 2.98 |
| Spi1 SRX2499695 | Scid.adh.2c2 Blood | 2710 / 14880 (18.2%) | 9101 / 148800 (6.1%) | −324.0 | −324.0 | 2.98 |
| Smc1a SRX7348146 | CD4 CD8 double positive cells Blood | 2609 / 14880 (17.5%) | 8790 / 148800 (5.9%) | −324.0 | −324.0 | 2.97 |
| Smc1a SRX7348141 | Thymocytes Blood | 2100 / 14880 (14.1%) | 7077 / 148800 (4.8%) | −324.0 | −324.0 | 2.97 |
| Spi1 SRX12298594 | B cells Blood | 2000 / 14880 (13.4%) | 6745 / 148800 (4.5%) | −324.0 | −324.0 | 2.97 |
| Runx3 SRX7554475 | CD8+ T cells Blood | 2665 / 14880 (17.9%) | 8988 / 148800 (6.0%) | −324.0 | −324.0 | 2.97 |
| Ikzf1 SRX205986 | B cells Blood | 3191 / 14880 (21.4%) | 10774 / 148800 (7.2%) | −324.0 | −324.0 | 2.96 |
| Smc1a SRX7348143 | CD4 CD8 double positive cells Blood | 2555 / 14880 (17.2%) | 8650 / 148800 (5.8%) | −324.0 | −324.0 | 2.95 |
| Hcfc1 SRX188815 | CH12 Blood | 1931 / 14880 (13.0%) | 6550 / 148800 (4.4%) | −324.0 | −324.0 | 2.95 |
| Runx1 SRX310206 | Mast Cells Blood | 3223 / 14880 (21.7%) | 10969 / 148800 (7.4%) | −324.0 | −324.0 | 2.94 |
| Rnf2 SRX3660770 | Bone Marrow Cells Blood | 2193 / 14880 (14.7%) | 7479 / 148800 (5.0%) | −324.0 | −324.0 | 2.93 |
| Sin3a SRX188801 | CH12 Blood | 2553 / 14880 (17.2%) | 8730 / 148800 (5.9%) | −324.0 | −324.0 | 2.92 |
| Rela SRX6074119 | MEF Embryonic fibroblast | 2690 / 14880 (18.1%) | 9220 / 148800 (6.2%) | −324.0 | −324.0 | 2.92 |
| AML1-ETO SRX3491901 | Spleen Spleen | 2149 / 14880 (14.4%) | 7403 / 148800 (5.0%) | −324.0 | −324.0 | 2.90 |
| Smc1a SRX7348144 | CD4 CD8 double positive cells Blood | 2697 / 14880 (18.1%) | 9340 / 148800 (6.3%) | −324.0 | −324.0 | 2.89 |
| Kmt2a SRX17605404 | Granulocytic-monocytic progenitors Blood | 2508 / 14880 (16.9%) | 8704 / 148800 (5.8%) | −324.0 | −324.0 | 2.88 |
| Spi1 SRX2499697 | Scid.adh.2c2 Blood | 2767 / 14880 (18.6%) | 9634 / 148800 (6.5%) | −324.0 | −324.0 | 2.87 |
| Spi1 SRX2341955 | Hematopoietic Stem Cells Blood | 2071 / 14880 (13.9%) | 7233 / 148800 (4.9%) | −324.0 | −324.0 | 2.86 |
| Smarca4 SRX8693962 | Neutrophils Blood | 2357 / 14880 (15.8%) | 8277 / 148800 (5.6%) | −324.0 | −324.0 | 2.85 |
| Ctcf SRX10095030 | Bone Marrow Cells Blood | 3221 / 14880 (21.6%) | 11322 / 148800 (7.6%) | −324.0 | −324.0 | 2.84 |
| Mxi1 SRX140391 | MEL Blood | 2477 / 14880 (16.6%) | 8754 / 148800 (5.9%) | −324.0 | −324.0 | 2.83 |
| Brd4 SRX1597806 | MLL-AF9 leukemic cell Blood | 2151 / 14880 (14.5%) | 7615 / 148800 (5.1%) | −324.0 | −324.0 | 2.82 |
| Gata3 SRX2499767 | Scid.adh.2c2 Blood | 2254 / 14880 (15.1%) | 7993 / 148800 (5.4%) | −324.0 | −324.0 | 2.82 |
| Ep300 SRX183951 | Th1 Cells Blood | 2672 / 14880 (18.0%) | 9478 / 148800 (6.4%) | −324.0 | −324.0 | 2.82 |
| Spi1 SRX1056343 | 416B Blood | 2483 / 14880 (16.7%) | 8816 / 148800 (5.9%) | −324.0 | −324.0 | 2.82 |
| Eomes SRX4510927 | OT-1 Blood | 2116 / 14880 (14.2%) | 7515 / 148800 (5.1%) | −324.0 | −324.0 | 2.82 |
| Whsc1l1 SRX1114542 | MLL-AF9 leukemic cell Blood | 3038 / 14880 (20.4%) | 10809 / 148800 (7.3%) | −324.0 | −324.0 | 2.81 |
| Spi1 SRX886478 | B-ALL Blood | 3057 / 14880 (20.5%) | 10881 / 148800 (7.3%) | −324.0 | −324.0 | 2.81 |
| Spi1 SRX2341954 | Hematopoietic Stem Cells Blood | 2215 / 14880 (14.9%) | 7934 / 148800 (5.3%) | −324.0 | −324.0 | 2.79 |
| Hdac2 SRX1815513 | B cells Blood | 3192 / 14880 (21.5%) | 11444 / 148800 (7.7%) | −324.0 | −324.0 | 2.79 |
| Chd4 SRX3660753 | Bone Marrow Cells Blood | 2370 / 14880 (15.9%) | 8509 / 148800 (5.7%) | −324.0 | −324.0 | 2.79 |
| Nfib SRX19694892 | C3H/10T1/2 Embryonic fibroblast | 2357 / 14880 (15.8%) | 8500 / 148800 (5.7%) | −324.0 | −324.0 | 2.77 |
| Epitope tags SRX6370145 | G1E Blood | 2607 / 14880 (17.5%) | 9407 / 148800 (6.3%) | −324.0 | −324.0 | 2.77 |
| Kmt2d SRX17605402 | Leukemia Blood | 2562 / 14880 (17.2%) | 9268 / 148800 (6.2%) | −324.0 | −324.0 | 2.76 |
| AML1-ETO SRX3491900 | Spleen Spleen | 2384 / 14880 (16.0%) | 8627 / 148800 (5.8%) | −324.0 | −324.0 | 2.76 |
| Spi1 SRX2188529 | Pro-B cells Blood | 2349 / 14880 (15.8%) | 8551 / 148800 (5.7%) | −324.0 | −324.0 | 2.75 |
| Bcl11b SRX2399084 | Thymocytes Blood | 4220 / 14880 (28.4%) | 15363 / 148800 (10.3%) | −324.0 | −324.0 | 2.75 |
| Spi1 SRX2499683 | CD25+ cells Blood | 2456 / 14880 (16.5%) | 8957 / 148800 (6.0%) | −324.0 | −324.0 | 2.74 |
| Runx1 SRX3660775 | CD4 CD8 double negative cells Blood | 3394 / 14880 (22.8%) | 12399 / 148800 (8.3%) | −324.0 | −324.0 | 2.74 |
| Runx1 SRX3195539 | CD4 CD8 double negative cells Blood | 3335 / 14880 (22.4%) | 12187 / 148800 (8.2%) | −324.0 | −324.0 | 2.74 |
| Runx1 SRX3660776 | CD4 CD8 double negative cells Blood | 3337 / 14880 (22.4%) | 12195 / 148800 (8.2%) | −324.0 | −324.0 | 2.74 |
| Runx1 SRX3195537 | CD4 CD8 double negative cells Blood | 3392 / 14880 (22.8%) | 12412 / 148800 (8.3%) | −324.0 | −324.0 | 2.73 |
| Phf8 SRX2396658 | Prostate Prostate | 2169 / 14880 (14.6%) | 7937 / 148800 (5.3%) | −324.0 | −324.0 | 2.73 |
| Spi1 SRX2499684 | CD25+ cells Blood | 2448 / 14880 (16.5%) | 8981 / 148800 (6.0%) | −324.0 | −324.0 | 2.73 |
| Epitope tags SRX6370147 | G1E Blood | 2530 / 14880 (17.0%) | 9285 / 148800 (6.2%) | −324.0 | −324.0 | 2.72 |
| Ascl1 SRX8886261 | Lung tumors Lung | 2453 / 14880 (16.5%) | 9019 / 148800 (6.1%) | −324.0 | −324.0 | 2.72 |
| Hdac2 SRX3660759 | CD4 CD8 double negative cells Blood | 3054 / 14880 (20.5%) | 11241 / 148800 (7.6%) | −324.0 | −324.0 | 2.72 |
| Spi1 SRX7368532 | B cells Blood | 2628 / 14880 (17.7%) | 9675 / 148800 (6.5%) | −324.0 | −324.0 | 2.72 |
| Runx3 SRX7554476 | CD8+ T cells Blood | 2682 / 14880 (18.0%) | 9912 / 148800 (6.7%) | −324.0 | −324.0 | 2.71 |
| Smarca4 SRX8693963 | Neutrophils Blood | 2601 / 14880 (17.5%) | 9642 / 148800 (6.5%) | −324.0 | −324.0 | 2.70 |
| Kdm1a SRX3660771 | CD4 CD8 double negative cells Blood | 2940 / 14880 (19.8%) | 10930 / 148800 (7.3%) | −324.0 | −324.0 | 2.69 |
| Chd4 SRX3660752 | CD4 CD8 double negative cells Blood | 2681 / 14880 (18.0%) | 9972 / 148800 (6.7%) | −324.0 | −324.0 | 2.69 |
| Phf8 SRX2396660 | Prostate Prostate | 2244 / 14880 (15.1%) | 8383 / 148800 (5.6%) | −324.0 | −324.0 | 2.68 |
| Runx2 SRX17733008 | ATDC-5 Pluripotent stem cell | 2433 / 14880 (16.4%) | 9186 / 148800 (6.2%) | −324.0 | −324.0 | 2.65 |
| Nelfa SRX6714137 | Heart Cardiovascular | 2331 / 14880 (15.7%) | 8817 / 148800 (5.9%) | −324.0 | −324.0 | 2.64 |
| Hdac2 SRX3660760 | CD4 CD8 double negative cells Blood | 3384 / 14880 (22.7%) | 12809 / 148800 (8.6%) | −324.0 | −324.0 | 2.64 |
| Rad21 SRX2755282 | B cells Blood | 2607 / 14880 (17.5%) | 9873 / 148800 (6.6%) | −324.0 | −324.0 | 2.64 |
| Kdm1a SRX3660772 | CD4 CD8 double negative cells Blood | 3057 / 14880 (20.5%) | 11588 / 148800 (7.8%) | −324.0 | −324.0 | 2.64 |
| Sin3a SRX188800 | MEL Blood | 2774 / 14880 (18.6%) | 10532 / 148800 (7.1%) | −324.0 | −324.0 | 2.63 |
| Chd4 SRX3660754 | Bone Marrow Cells Blood | 2732 / 14880 (18.4%) | 10425 / 148800 (7.0%) | −324.0 | −324.0 | 2.62 |
| Spi1 SRX2341958 | Granulocytic-monocytic progenitors Blood | 2422 / 14880 (16.3%) | 9328 / 148800 (6.3%) | −324.0 | −324.0 | 2.60 |
| Smarcc1 SRX8673311 | Tumor Others | 2963 / 14880 (19.9%) | 11468 / 148800 (7.7%) | −324.0 | −324.0 | 2.58 |
| Ep300 SRX8379016 | Macrophages Blood | 2444 / 14880 (16.4%) | 9500 / 148800 (6.4%) | −324.0 | −324.0 | 2.57 |
| Ep300 SRX8379017 | Macrophages Blood | 2556 / 14880 (17.2%) | 9962 / 148800 (6.7%) | −324.0 | −324.0 | 2.57 |
| Runx1 SRX3660777 | Bone Marrow Cells Blood | 2682 / 14880 (18.0%) | 10466 / 148800 (7.0%) | −324.0 | −324.0 | 2.56 |
| Runx2 SRX17733007 | ATDC-5 Pluripotent stem cell | 2557 / 14880 (17.2%) | 10014 / 148800 (6.7%) | −324.0 | −324.0 | 2.55 |
| Ep300 SRX183950 | Th1 Cells Blood | 2395 / 14880 (16.1%) | 9410 / 148800 (6.3%) | −324.0 | −324.0 | 2.55 |
| Spi1 SRX7368539 | B cells Blood | 3166 / 14880 (21.3%) | 12458 / 148800 (8.4%) | −324.0 | −324.0 | 2.54 |
| Nelfa SRX6714136 | Heart Cardiovascular | 2379 / 14880 (16.0%) | 9415 / 148800 (6.3%) | −324.0 | −324.0 | 2.53 |
| Spi1 SRX2341959 | Granulocytic-monocytic progenitors Blood | 2507 / 14880 (16.8%) | 10013 / 148800 (6.7%) | −324.0 | −324.0 | 2.50 |
| Nr3c1 SRX4615043 | Lung endothelial cells Cardiovascular | 2578 / 14880 (17.3%) | 10307 / 148800 (6.9%) | −324.0 | −324.0 | 2.50 |
| Epitope tags SRX6370146 | G1E Blood | 2830 / 14880 (19.0%) | 11442 / 148800 (7.7%) | −324.0 | −324.0 | 2.47 |
| Spi1 SRX310205 | Mast Cells Blood | 3619 / 14880 (24.3%) | 14653 / 148800 (9.8%) | −324.0 | −324.0 | 2.47 |
| Irf4 SRX2162564 | Pre-B cells Blood | 2545 / 14880 (17.1%) | 10329 / 148800 (6.9%) | −324.0 | −324.0 | 2.46 |
| Ctcf SRX10095027 | Bone Marrow Cells Blood | 3849 / 14880 (25.9%) | 15647 / 148800 (10.5%) | −324.0 | −324.0 | 2.46 |
| Spi1 SRX2499685 | CD25+ cells Blood | 2905 / 14880 (19.5%) | 11842 / 148800 (8.0%) | −324.0 | −324.0 | 2.45 |
| Nr3c1 SRX4615040 | Lung endothelial cells Cardiovascular | 2625 / 14880 (17.6%) | 10946 / 148800 (7.4%) | −324.0 | −324.0 | 2.40 |
| Kdm1a SRX3660774 | Bone Marrow Cells Blood | 3118 / 14880 (21.0%) | 13034 / 148800 (8.8%) | −324.0 | −324.0 | 2.39 |
| Epitope tags SRX6370142 | G1E Blood | 2998 / 14880 (20.1%) | 12542 / 148800 (8.4%) | −324.0 | −324.0 | 2.39 |
| Kdm1a SRX3660773 | Bone Marrow Cells Blood | 2963 / 14880 (19.9%) | 12426 / 148800 (8.4%) | −324.0 | −324.0 | 2.38 |
| Rad21 SRX3753624 | B cells Blood | 2820 / 14880 (19.0%) | 11883 / 148800 (8.0%) | −324.0 | −324.0 | 2.37 |
| Spi1 SRX2980171 | Myeloid leukemia Blood | 2655 / 14880 (17.8%) | 11219 / 148800 (7.5%) | −324.0 | −324.0 | 2.37 |
| Epitope tags SRX6370144 | G1E Blood | 2986 / 14880 (20.1%) | 12624 / 148800 (8.5%) | −324.0 | −324.0 | 2.37 |
| Hdac2 SRX3660762 | Bone Marrow Cells Blood | 3202 / 14880 (21.5%) | 13549 / 148800 (9.1%) | −324.0 | −324.0 | 2.36 |
| Spi1 SRX1939448 | Lymphoid-primed multipotent progenitors Blood | 3281 / 14880 (22.0%) | 13962 / 148800 (9.4%) | −324.0 | −324.0 | 2.35 |
| Spi1 SRX7821062 | Hematopoietic progenitors Blood | 3275 / 14880 (22.0%) | 13963 / 148800 (9.4%) | −324.0 | −324.0 | 2.35 |
| Runx1 SRX3660778 | Bone Marrow Cells Blood | 3157 / 14880 (21.2%) | 13603 / 148800 (9.1%) | −324.0 | −324.0 | 2.32 |
| Hdac2 SRX3660761 | Bone Marrow Cells Blood | 3095 / 14880 (20.8%) | 13355 / 148800 (9.0%) | −324.0 | −324.0 | 2.32 |
| Biotin SRX273254 | B cells Blood | 2950 / 14880 (19.8%) | 12730 / 148800 (8.6%) | −324.0 | −324.0 | 2.32 |
| Epitope tags SRX6370143 | G1E Blood | 3264 / 14880 (21.9%) | 14415 / 148800 (9.7%) | −324.0 | −324.0 | 2.26 |
| Fli1 SRX884086 | MLL-AF9 leukemic cell Blood | 3077 / 14880 (20.7%) | 13656 / 148800 (9.2%) | −324.0 | −324.0 | 2.25 |
| Fli1 SRX884087 | MLL-AF9 leukemic cell Blood | 3410 / 14880 (22.9%) | 16127 / 148800 (10.8%) | −324.0 | −324.0 | 2.11 |
| Erg SRX884089 | MLL-AF9 leukemic cell Blood | 3559 / 14880 (23.9%) | 17258 / 148800 (11.6%) | −324.0 | −324.0 | 2.06 |
| Epitope tags SRX7884347 | Acute myeloid leukemia Blood | 880 / 14880 (5.9%) | 1400 / 148800 (0.9%) | −323.3 | −321.6 | 6.29 |
| Tcf3 SRX1568865 | Unclassified Unclassified | 1296 / 14880 (8.7%) | 3212 / 148800 (2.2%) | −323.3 | −321.6 | 4.03 |
| Gfi1 SRX5131513 | Medulloblastoma Neural | 1849 / 14880 (12.4%) | 6187 / 148800 (4.2%) | −322.7 | −321.0 | 2.99 |
| Epitope tags SRX7884346 | Acute myeloid leukemia Blood | 821 / 14880 (5.5%) | 1187 / 148800 (0.8%) | −322.6 | −320.9 | 6.92 |
| Zfp384 SRX2324494 | Spermatogonia Gonad | 2273 / 14880 (15.3%) | 8766 / 148800 (5.9%) | −322.5 | −320.8 | 2.59 |
| Taf1 SRX19028406 | ES cells Pluripotent stem cell | 1708 / 14880 (11.5%) | 5388 / 148800 (3.6%) | −322.1 | −320.4 | 3.17 |
| Max SRX140371 | CH12 Blood | 2060 / 14880 (13.8%) | 7459 / 148800 (5.0%) | −321.4 | −319.7 | 2.76 |
| Ascl1 SRX8886262 | Lung tumors Lung | 2099 / 14880 (14.1%) | 7698 / 148800 (5.2%) | −321.3 | −319.6 | 2.73 |
| Sp1 SRX7799921 | CH12 Blood | 1818 / 14880 (12.2%) | 6027 / 148800 (4.1%) | −321.1 | −319.4 | 3.02 |
| Max SRX140382 | MEL Blood | 1961 / 14880 (13.2%) | 6873 / 148800 (4.6%) | −320.6 | −318.9 | 2.85 |
| Ing5 SRX14210166 | ES cells Pluripotent stem cell | 2310 / 14880 (15.5%) | 9048 / 148800 (6.1%) | −319.6 | −317.9 | 2.55 |
| Spi1 SRX2499689 | CD25+ cells Blood | 1618 / 14880 (10.9%) | 4929 / 148800 (3.3%) | −318.8 | −317.1 | 3.28 |
| Rad21 SRX7508562 | Pro-B cells Blood | 1275 / 14880 (8.6%) | 3157 / 148800 (2.1%) | −318.0 | −316.3 | 4.04 |
| Spi1 SRX8693957 | Neutrophils Blood | 2210 / 14880 (14.9%) | 8438 / 148800 (5.7%) | −318.0 | −316.3 | 2.62 |
| Spi1 SRX8030788 | Acute myeloid leukemia Blood | 2059 / 14880 (13.8%) | 7503 / 148800 (5.0%) | −318.0 | −316.3 | 2.74 |
| Tcf7 SRX24130479 | Thymocytes Blood | 1420 / 14880 (9.5%) | 3884 / 148800 (2.6%) | −317.9 | −316.2 | 3.66 |
| Runx1 SRX1901620 | G1E Blood | 1524 / 14880 (10.2%) | 4433 / 148800 (3.0%) | −317.6 | −315.9 | 3.44 |
| Pcgf1 DRX053276 | MEL Blood | 1239 / 14880 (8.3%) | 2989 / 148800 (2.0%) | −317.4 | −315.7 | 4.15 |
| Spi1 SRX2997922 | Hematopoietic Stem Cells Blood | 3142 / 14880 (21.1%) | 14733 / 148800 (9.9%) | −317.3 | −315.6 | 2.13 |
| Zfp384 SRX2324495 | Spermatogonia Gonad | 2054 / 14880 (13.8%) | 7483 / 148800 (5.0%) | −317.2 | −315.5 | 2.74 |
| Brd4 SRX3113705 | CD4+ T cells Blood | 930 / 14880 (6.3%) | 1631 / 148800 (1.1%) | −317.0 | −315.3 | 5.70 |
| Spi1 SRX2499720 | Scid.adh.2c2 Blood | 1495 / 14880 (10.0%) | 4293 / 148800 (2.9%) | −316.3 | −314.6 | 3.48 |
| Brd4 SRX5782039 | Leukemia stem cell lines Blood | 616 / 14880 (4.1%) | 565 / 148800 (0.4%) | −315.7 | −314.0 | 10.90 |
| Bcl11a SRX8030787 | Acute myeloid leukemia Blood | 1097 / 14880 (7.4%) | 2347 / 148800 (1.6%) | −315.6 | −313.9 | 4.67 |
| Med12 SRX5086065 | Th2 Cells Blood | 1055 / 14880 (7.1%) | 2168 / 148800 (1.5%) | −314.8 | −313.1 | 4.87 |
| Epitope tags SRX24288473 | Pro-B cells Blood | 1073 / 14880 (7.2%) | 2251 / 148800 (1.5%) | −314.2 | −312.5 | 4.77 |
| Spi1 SRX2499688 | CD25+ cells Blood | 1611 / 14880 (10.8%) | 4968 / 148800 (3.3%) | −312.2 | −310.5 | 3.24 |
| Brd4 SRX3602879 | iPS cells Pluripotent stem cell | 1078 / 14880 (7.2%) | 2291 / 148800 (1.5%) | −311.9 | −310.2 | 4.71 |
| Spi1 SRX2499694 | Scid.adh.2c2 Blood | 1297 / 14880 (8.7%) | 3330 / 148800 (2.2%) | −311.1 | −309.4 | 3.89 |
| Nipbl SRX13845192 | Scid.adh.2c2 Blood | 961 / 14880 (6.5%) | 1797 / 148800 (1.2%) | −310.9 | −309.2 | 5.35 |
| Irf4 SRX1131942 | Plasmablasts Blood | 1330 / 14880 (8.9%) | 3497 / 148800 (2.4%) | −310.9 | −309.2 | 3.80 |
| Foxp3 SRX3829344 | Treg Blood | 1152 / 14880 (7.7%) | 2643 / 148800 (1.8%) | −310.0 | −308.3 | 4.36 |
| Rag2 SRX018807 | Thymocytes Blood | 953 / 14880 (6.4%) | 1772 / 148800 (1.2%) | −309.7 | −308.0 | 5.38 |
| Pou2f1 SRX7368547 | B cells Blood | 1146 / 14880 (7.7%) | 2618 / 148800 (1.8%) | −309.7 | −308.0 | 4.38 |
| Epitope tags SRX2486173 | ES cells Pluripotent stem cell | 1797 / 14880 (12.1%) | 6057 / 148800 (4.1%) | −309.6 | −307.9 | 2.97 |
| Phf8 SRX15939565 | NIH/3T3 Embryonic fibroblast | 1244 / 14880 (8.4%) | 3087 / 148800 (2.1%) | −309.2 | −307.6 | 4.03 |
| Spi1 SRX2997920 | Hematopoietic Stem Cells Blood | 3218 / 14880 (21.6%) | 15462 / 148800 (10.4%) | −308.8 | −307.2 | 2.08 |
| Epitope tags SRX9195292 | ES cells Pluripotent stem cell | 1417 / 14880 (9.5%) | 3964 / 148800 (2.7%) | −308.8 | −307.1 | 3.57 |
| Elf1 SRX12734919 | Granulocyte-Macrophage Progenitor Cells Blood | 1294 / 14880 (8.7%) | 3338 / 148800 (2.2%) | −308.7 | −307.0 | 3.88 |
| Hdac1 SRX7726757 | B cells Blood | 1162 / 14880 (7.8%) | 2706 / 148800 (1.8%) | −308.1 | −306.4 | 4.29 |
| Nipbl SRX8693945 | Neutrophils Blood | 2042 / 14880 (13.7%) | 7549 / 148800 (5.1%) | −307.9 | −306.3 | 2.70 |
| Ncaph2 SRX1688321 | ES cells Pluripotent stem cell | 1791 / 14880 (12.0%) | 6045 / 148800 (4.1%) | −307.8 | −306.1 | 2.96 |
| Ikzf1 SRX8994274 | B cells Blood | 901 / 14880 (6.1%) | 1575 / 148800 (1.1%) | −307.7 | −306.1 | 5.72 |
| Tet2 SRX4232706 | Hematopoietic cells Blood | 1251 / 14880 (8.4%) | 3136 / 148800 (2.1%) | −307.6 | −306.0 | 3.99 |
| Relb SRX20904785 | Dendritic Cells Blood | 3138 / 14880 (21.1%) | 14916 / 148800 (10.0%) | −307.4 | −305.7 | 2.10 |
| Brd4 SRX8934800 | B cells Blood | 907 / 14880 (6.1%) | 1602 / 148800 (1.1%) | −307.2 | −305.6 | 5.66 |
| Myc SRX8012787 | Fibroblasts Others | 1539 / 14880 (10.3%) | 4636 / 148800 (3.1%) | −306.9 | −305.2 | 3.32 |
| Rnf2 SRX7278120 | Hematopoietic progenitors Blood | 842 / 14880 (5.7%) | 1353 / 148800 (0.9%) | −306.6 | −305.0 | 6.22 |
| Brd4 SRX2172627 | iPS cells Pluripotent stem cell | 1472 / 14880 (9.9%) | 4281 / 148800 (2.9%) | −306.3 | −304.6 | 3.44 |
| Kmt2a SRX25655410 | Leukemia Blood | 1370 / 14880 (9.2%) | 3752 / 148800 (2.5%) | −305.8 | −304.1 | 3.65 |
| Epitope tags SRX2357488 | Embryonic kidney Embryo | 1202 / 14880 (8.1%) | 2918 / 148800 (2.0%) | −305.5 | −303.9 | 4.12 |
| Myc SRX140369 | CH12 Blood | 1774 / 14880 (11.9%) | 5978 / 148800 (4.0%) | −305.5 | −303.8 | 2.97 |
| Stat4 SRX7726452 | Natural killer cells Blood | 1524 / 14880 (10.2%) | 4584 / 148800 (3.1%) | −304.3 | −302.6 | 3.32 |
| Spi1 SRX2997921 | Hematopoietic Stem Cells Blood | 2861 / 14880 (19.2%) | 13022 / 148800 (8.8%) | −304.0 | −302.3 | 2.20 |
| Fli1 SRX203227 | Megakaryocytes Blood | 1519 / 14880 (10.2%) | 4562 / 148800 (3.1%) | −303.9 | −302.2 | 3.33 |
| Stat2 SRX2647476 | CD4+ T cells Blood | 1088 / 14880 (7.3%) | 2400 / 148800 (1.6%) | −303.9 | −302.2 | 4.53 |
| Asxl1 SRX1471726 | Mesenchymal stem cells Others | 1660 / 14880 (11.2%) | 5346 / 148800 (3.6%) | −303.8 | −302.1 | 3.11 |
| Biotin SRX5578684 | ES cells Pluripotent stem cell | 1239 / 14880 (8.3%) | 3114 / 148800 (2.1%) | −303.7 | −302.1 | 3.98 |
| Smc1a SRX20340934 | Pre-B cells Blood | 2440 / 14880 (16.4%) | 10166 / 148800 (6.8%) | −303.5 | −301.9 | 2.40 |
| Kmt2a SRX25655412 | Leukemia Blood | 1290 / 14880 (8.7%) | 3370 / 148800 (2.3%) | −303.4 | −301.7 | 3.83 |
Showing first 500 of 12555 rows.